SCHEMBL4111159

SCHEMBL4111159

COc1cccc(C(=O)c2cc(Cl)ccc2-n2cccc2)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
RORC P51449 3/20 0.40
RORB Q92753 3/20 0.40
NPC1 O15118 3/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 3/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KCNMA1 Q12791 1/20 0.39
HIF1A Q16665 1/20 0.39
RAB9A P51151 2/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119261 0.88 L3MBTL1 (0.50) L3MBTL1RORCRORBNPC1ALOX15
SCHEMBL4122687 0.87 L3MBTL1 (0.44) L3MBTL1RORCRORBNPC1KMT2A
SCHEMBL4118982 0.84 LMNA (0.41) L3MBTL1TSHRKDM4ETUBB4ATUBB
SCHEMBL4117233 0.83 L3MBTL1 (0.41) L3MBTL1ALOX15TSHRKMT2AGAA
SCHEMBL4110400 0.82 GAA (0.49) L3MBTL1RORCRORBGAAALDH1A1
SCHEMBL15641368 0.81 RECQL (0.55) RORCRORBNPC1KMT2AKDM4E
SCHEMBL4121868 0.79 GAA (0.37) RORCRORBGAAKDM4ELMNA
SCHEMBL4121864 0.79 GAA (0.37) RORCRORBGAAKDM4ELMNA
SCHEMBL4110426 0.79 TUBB4A (0.42) L3MBTL1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13775456 0.78 NR1H4 (0.37) RORCRORBKMT2AGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR L3MBTL1 661/4885RORC 2588/4885RORB 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.